asmanex twisthaler 400 mikrog/annos inhalaatiojauhe
n.v. organon - mometasone furoate - inhalaatiojauhe - 400 mikrog/annos - mometasoni
mommox 50 mikrog/annos nenäsumute, suspensio
sandoz a/s - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
nenoxin 50 mikrog/annos nenäsumute, suspensio
oy verman ab - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
momesonex 50 mikrog/annos nenäsumute, suspensio
teva pharma b.v. - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
ryaltris 25 mikrogrammaa / annos + 600 mikrogrammaa / annos nenäsumute, suspensio
glenmark pharmaceuticals s.r.o. - mometasone furoate monohydrate, olopatadine hydrochloride - nenäsumute, suspensio - 25 mikrogrammaa / annos + 600 mikrogrammaa / annos - mometasoni
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
posatex
intervet international bv - orbifloksasiinia, mometasone furoate, posakonatsoli - korvatautien lääkkeet - koirat - akuutin ulkokorvatulehduksen ja akuutisti pahentuneen toistuvan ulkokorvantulehduksen, jotka liittyvät bakteerit alttiita orbifloksasiinia ja sienet alttiita posakonatsoli, erityisesti malassezia pachydermatis-hiivaa.
bemetson-k voide
orion oyj - betamethasoni 17-valeras,clioquinolum - voide - beetametasoni ja antiseptit
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.